Efficacy of low-dose radioablation therapy using 740 MBq of I131 in postoperative differentiated thyroid cancer patients. An Initial Experience

被引：0
|
作者：
Iordanidou, L. [1 ]
Papadouli, D. [1 ]
Sevaslidou, I. [1 ]
Trekla, S. [1 ]
Erifillidou, M. [1 ]
Pateniotis, K. [1 ]
Trivizaki, E. [1 ]
机构：
[1] Metaxa Canc Hosp, Piraeus, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0460
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [41] Efficacy of 131I SPECT/CT in the Initial Nodal Staging in Patients with Differentiated Thyroid Carcinoma at the First Ablative Radioiodine Therapy
    Kisiel, N.
    Garcia-Burillo, A.
    Barios, M.
    Dellepiane, F.
    Castell-Conesa, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S278 - S278
  • [42] Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
    Verburg, Frederik A.
    Haenscheid, Heribert
    Biko, Johannes
    Hategan, Maria C.
    Lassmann, Michael
    Kreissl, Michael C.
    Reiners, Christoph
    Luster, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) : 896 - 903
  • [43] Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
    Frederik A. Verburg
    Heribert Hänscheid
    Johannes Biko
    Maria C. Hategan
    Michael Lassmann
    Michael C. Kreissl
    Christoph Reiners
    Markus Luster
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 896 - 903
  • [44] Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Wakabayashi, Hiroshi
    Taki, Junichi
    Inaki, Anri
    Nakamura, Ayane
    Kayano, Daiki
    Fukuoka, Makoto
    Matsuo, Shinro
    Nakajima, Kenichi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (09) : 839 - 846
  • [45] Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Hiroshi Wakabayashi
    Junichi Taki
    Anri Inaki
    Ayane Nakamura
    Daiki Kayano
    Makoto Fukuoka
    Shinro Matsuo
    Kenichi Nakajima
    Seigo Kinuya
    Annals of Nuclear Medicine, 2013, 27 : 839 - 846
  • [46] Comparison of 1.1 gbq and 2.2 gbq131I activities in patients with low-risk differentiated thyroid cancer requiring postoperative iodine-131 therapy.
    Campenni, A.
    Ruggeri, R.
    Garo, M.
    Raffa, A.
    Siracusa, M.
    Restuccia, G.
    Rappazzo, A.
    Rosarno, H.
    Nicocia, A.
    Cardile, D.
    Ovcaricek, P. Petranovic
    Baldari, S.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S171 - S172
  • [47] Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
    Heribert Hänscheid
    Frederik Anton Verburg
    Johannes Biko
    Stefanie Dießl
    Yuri E. Demidchik
    Valentina Drozd
    Christoph Reiners
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1296 - 1302
  • [48] Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
    Haenscheid, Heribert
    Verburg, Frederik Anton
    Biko, Johannes
    Diessl, Stefanie
    Demidchik, Yuri E.
    Drozd, Valentina
    Reiners, Christoph
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (07) : 1296 - 1302
  • [49] Low-dose radioiodine therapy versus reoperation in patients after non-radical thyroidectomy with differentiated thyroid cancer
    Vasilenko, E.
    Karalkina, M.
    Lagozhina, I.
    Fomin, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S327 - S328
  • [50] EFFECTIVE HALF-LIFE OF I-131 IN THYROID CARCINOMA PATIENTS RECEIVING LOW-DOSE ABLATION THERAPY WITH RTSH
    Willowson, K.
    Bailey, D.
    Forwood, N.
    Bailey, E.
    Roach, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 35 - 35
12345